Agios Pharmaceuticals Inc AGIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/29/22 EDT
28.57quote price arrow up+28.57 (UNCH)
Volume
48,340
Close
28.57quote price arrow down-0.81 (-2.76%)
Volume
427,225
52 week range
16.75 - 50.98
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close28.57
  • 52 Week High50.98
  • 52 Week High Date11/04/21
  • 52 Week Low16.75
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap1.566B
  • Shares Out54.82M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta1.03
  • YTD % Change-13.08

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close28.57
  • 52 Week High50.98
  • 52 Week High Date11/04/21
  • 52 Week Low16.75
  • 52 Week Low Date06/16/22
  • Market Cap1.566B
  • Shares Out54.82M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta1.03
  • YTD % Change-13.08

RATIOS/PROFITABILITY

  • EPS (TTM)-6.71
  • P/E (TTM)-4.26
  • Fwd P/E (NTM)-4.42
  • EBITDA (TTM)-385.584M
  • ROE (TTM)-25.96%
  • Revenue (TTM)6.41M
  • Gross Margin (TTM)87.93%
  • Net Margin (TTM)-5,759.64%
  • Debt To Equity (MRQ)0.11%

EVENTS

  • Earnings Date11/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Agios Pharmaceuticals Inc

 

Profile

MORE
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of...
Jacqualyn Fouse Ph.D.
Chairman of the Board
Brian Goff
Chief Executive Officer, Director
Cecilia Jones
Chief Financial Officer
T. J. Washburn
Principal Accounting Officer
Address
88 Sidney Street
Cambridge, MA
02139
United States

Top Peers

SYMBOLLASTCHG%CHG
IOVA
Iovance Biotherapeutics Inc
9.53-0.71-6.93%
ALLO
Allogene Therapeutics Inc
10.32-1.11-9.71%
SAVA
Cassava Sciences Inc
43.07-0.77-1.76%
LYEL
Lyell Immunopharma Inc
7.41-0.48-6.08%
VERV
Verve Therapeutics Inc
34.20-0.28-0.81%